Jennifer Buell Agenus Inc (AGEN) insider trading activity

Jennifer Buell is of AGENUS INC. Currently has a direct ownership of 15,646 shares of AGEN, which is worth approximately $261,131. The most recent transaction as insider was on Mar 07, 2025, when has been sold 409 shares (Common Stock) at a price of $2.35 per share, resulting in proceeds of $961. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.6K

87.69% 3M change

87.69% 12M change

Total Value Held $261,131

Jennifer Buell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2025	BUY Grant, award, or other acquisition	$961 $2.35 p/Share	409 Added 2.55%	15,646 Common Stock
Feb 21 2025	BUY Grant, award, or other acquisition	$1,809 $3.32 p/Share	545 Added 3.45%	15,237 Common Stock
Feb 21 2025	BUY Grant, award, or other acquisition	$2,078 $3.32 p/Share	626 Added 3.93%	15,318 Common Stock
Feb 07 2025	BUY Grant, award, or other acquisition	$1,806 $3.5 p/Share	516 Added 3.39%	14,692 Common Stock
Jan 24 2025	SELL Payment of exercise price or tax liability	$963 $3.57 p/Share	270 Reduced 1.87%	14,176 Common Stock
Jan 24 2025	BUY Grant, award, or other acquisition	$2,770 $3.57 p/Share	776 Added 5.1%	14,446 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$58,178 $5.49 p/Share	10,597 Added 7.7%	127,091 Common Stock
Apr 02 2021	BUY Grant, award, or other acquisition	$232,005 $2.87 p/Share	80,838 Added 40.97%	116,494 Common Stock

Also insider at

INKT

MiNK Therapeutics, Inc. Healthcare

Chief Executive Officer

PTIXW

Protagenic Therapeutics, Inc.new ETFs

Director

Jennifer Buell

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Agenus Inc insider buys or sells AGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AGENUS INC

Track Activities on AGEN

Account